Wednesday, February 15, 2017

Versant-backed Jecure launches to tackle NASH

Biotech will use $20 million in funding to develop first-in class compounds

via Chemical & Engineering News: Biological SCENE http://ift.tt/2lOYVLp
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)